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August 2011592 AbstractsObjective: The National Kidney Foundation has recommended
utilizing autogenous arteriovenous fistulas (AVFs) in at least 50% of all
new patients with endstage renal disease (ESRD). Some studies suggest
that black patients are less likely to receive first time AVF than other
ethnicities, although the reason for this disparity is unclear. The purpose
of our study was to determine whether racial differences influence AVF
preference over grafts and whether this may be related to differences in
vein diameters.
Methods: Consecutive patients undergoing first-time hemodialysis
access from 2006 to 2010 at two institutions were retrospectively re-
viewed. Data collected included age, gender, ethnicity, weight, height,
body surface area (BSA), diabetes, hypertension, congestive heart failure,
smoking history, intravenous drug abuse, need for temporary access
placement, and preoperative venous ultrasound scan measurements.
Categorical variables were compared using 2 and odds ratios, whereas
the Wilcoxon-rank sum test was used to compare continuous variables.
Results: Two hundred eighty patients (99 black) were identified for
the study. Median age in black and nonblack patients was 63 years old. All
patients underwent preoperative duplex scan, and black patients demon-
strated statistically significant, smaller median basilic and cephalic vein
diameters at all measured sites except at the cephalic vein distal forearm
and proximal upper arm. Overall, 249 patients (90%) underwent AVF
first. Arteriovenous (AV) graft was created in 18% of black patients vs
only 7% of nonblacks (odds ratio [OR], 2.9; 95% confidence interval
[CI], 1.3-6.1; P .0005). Weight and BSA were statistically significantly
different between black and nonblack patients, whereas the need for
temporary access before hemoaccess was similar between the cohorts.
After adjusting for weight and BSA, black patients were still more likely
to undergo AV graft (OR, 2.9; 95% CI, 1.3-6.6; P  .007).
Conclusions: Black patients are less likely to undergo AVF during first
time hemodialysis access surgery, likely due to their smaller preoperative
measurements in basilic and cephalic vein diameters.
Duplex Ultrasound Criteria for Re-intervention after Mesenteric Ar-
tery Revascularization
Aaron C. Baker, Victoria Chew, Chin-Shang Li, PhD, Tzu-Chun Lin, David
L. Dawson, MD, William C. Pevec, MD, and Nasim Hedayati, MD,
Department of General Surgery, University of California Davis Health
System, Sacramento, Calif.
Objective: Currently, there are no well established duplex ultrasound
(DUS) scan criteria for the evaluation of the superior mesenteric artery
(SMA) after stenting for occlusive disease. Previous studies suggested DUS
velocity criteria in native SMA overestimate stenosis in stented arteries, but
no study has evaluated DUS after SMA stenting longitudinally. This study
was undertaken to determine the accuracy of DUS in evaluation of SMA
in-stent restenosis.
Methods: We identified all patients who underwent SMA/celiac artery
stenting and mesenteric bypass grafting from January 2004 to December
2010.
Results: Twenty-seven patients with symptomatic mesenteric ischemia
were treated with mesenteric stenting and 15 patients with mesenteric
bypass grafting. Eighteen pre-stent DUS showed SMA peak systolic velocity
(PSV) of 471  118 cm/second. Pre-stenting angiography revealed SMA
stenosis of 72  15%. Completion angiography revealed 15% residual
stenosis. No significant correlation was identified between SMA PSV and
angiographic stenosis pre-stenting and post-stenting. Follow-up SMA DUS
showed a PSV of 365  130 cm/seconds at 2  5 months, PSV of 377 
145 cm/seconds at 5 3 months, and a PSV of 375 103 cm/seconds at
15 4 months. A significant difference existed between pre-stenting and the
first post-stenting SMA PSV (P value  .05), but no significant difference
existed between each post-stenting interval. Six patients (5 asymptomatic, 1
symptomatic) had repeat mesenteric angiography for elevated SMA stent
PSV of 490  87 cm/seconds (vs 343  146 cm/seconds in patients who
did not undergo reintervention). Angiography demonstrated 57%  13
stenosis of the SMA. Four patients underwent re-stenting and 1 patient had
angioplasty. PSV decreased to 380 57 cm/seconds postprocedure. In the
patients who had SMA bypass grafting, DUS did not show a change in PSV
over time.
Conclusion: As has been previously shown in DUS studies of carotid
and renal artery stents, our data demonstrate that PSV in successfully stented
SMAs is higher than the PSV of 275 cm/seconds used for diagnosing
stenosis of non-stented SMAs. More importantly, PSV of stented SMAs do
not significantly change over time. DUS should be considered early after
mesenteric intervention to identify significant residual stenosis that may
need early reintervention and to provide a baseline for future follow-up.
Durability and Stroke-Free Survival after Carotid Stenting: Long-
Term Follow-up in a Community Setting
Peter A. Schneider, MD, Michael Peterson, MD, Michael T. Caps, MD, and
Nicolas Nelken, MD, Department of Vascular Therapy, Hawaii Permanente
Medical Group, Honolulu, Hawaii. VObjectives: The purpose of carotid angioplasty and stent (CAS) is
troke prevention. Large trials have been conducted or are underway to
nderstand the results of CAS. However, two significant questions remain:
1) What are the long-term results, beyond the reports of 2 to 4 years? (2)
o the results of major trials correlate with similar results in the community
t large? The purpose of this study is twofold: to evaluate the long-term
esults of CAS with respect to stroke-free survival, re-stenosis, and reinter-
ention; and, to assess the overall result of CAS in a community setting.
Methods:Over a 9-year period (2002-2010), we used CAS as a treatment
or significant carotid stenosis in 162 procedures in 150 patients. In most of the
atients, there was one or more anatomic or physiological indication for CAS
ue to high-risk status for carotid endarterectomy. After CAS, patients were
ollowed with surveillance duplex scan in a certified vascular laboratory at 1
onth, 6 months, 1 year, and annually thereafter. Peak systolic velocity (PSV)
200 cm/seconds was considered to be a re-stenosis of50% and PSV300
m/seconds was considered to be70% re-stenosis. Repeat interventions were
erformed at the discretion of the treating surgeon.
Results: The risk of perioperative stroke was 3.1% and death was 0.6%.
ean follow-up was 2.6 years with a range of 0 to 8.9 years. One hundred
wenty of the procedures (74%) had a follow-up of at least 1 year. Stroke-free
urvival at 1, 3, and 5 years was 91%, 70%, and 53%, respectively. Freedom from
ll causes of stroke was 96% at 1 year, 95% at 3 years, and 92% at 5 years.
e-stenosis of 50% or more occurred in 4% at 1 year, 8% at 3 years, and 8% at 5
ears. Re-stenosis of 70% or more occurred in 2% at 1 year, 6% at 3 years, and 6%
t 5 years. Only three (1.9%) of the index procedures required re-treatment.
one of the patients with recurrent stenosis presented with neurologic symp-
oms. None of the patients died of stroke during long-term follow-up.
Conclusion: Long-term stroke-free survival was diminished in this
opulation at high risk for carotid surgery. The rates of re-stenosis, reinter-
ention, and stroke from any cause were acceptable after CAS. These data
uggest that CAS can be performed in a community setting with acceptable
ong-term durability and stroke prevention.
erioperative Complications Associated with Femoral Vein Harvest
avi V. Dhanisetty, Timothy K. Liem, MD, Gregory L. Landry, MD, Erica
. Mitchell, MD, and Gregory L. Moneta, MD, Department of Surgery,
regon Health & Science University, Portland, Ore.
Objectives: The femoral vein is increasingly used as a conduit in
ajor arterial and venous reconstructions. However, the perioperative
omplications associated with femoral vein harvest (FVH) are not well
escribed. The purpose of this study was to determine the incidence and
isk factors for the development of deep venous thrombosis in patients
ho undergo FVH.
Methods: All patients who underwent FVH over a 5-year period were
eviewed. Patient clinical characteristics and indications for surgery were
etermined from an electronic medical record query. Postoperative venous
uplex scans and computerized tomography scans of the chest were re-
iewed. Data were analyzed using t test.
Results: Fifty-seven patients (53% male, mean age 62 years old)
nderwent 58 FVH procedures. Fifty-three percent of procedures were
erformed for arterial reconstruction and 47% for major venous recon-
truction after cancer resection (80% portomesenteric reconstruction).
erioperative ipsilateral deep venous thrombosis (DVT) was detected in
7 of 58 FVH procedures (29%). Eleven (19%) were isolated to the veins
istal to the FVH site, and 6 (10%) occurred proximal to the FVH site.
he incidence of DVT was significantly greater in patients with malig-
ancy (56% vs 13%; P value  .003). All DVTs proximal to the vein
arvest site occurred in patients with malignancy. Pulmonary embolism
ccurred in 2 patients, and none of the patients developed compartment
yndrome or limb loss. Eight patients (14%) required bedside or opera-
ive FVH wound debridement.
Conclusions: FVH is frequently associated with ipsilateral DVT, and the
ncidence is significantly higher in patients with malignancy. Aggressive throm-
oprophylaxis may be warranted after femoral vein harvest, especially in patients
ith known malignancy. Longer-term studies are needed to determine the
atural history of DVTs associated with femoral vein harvest.
evelopment of a Rapid, High Resolution Magnetic Resonance Imag-
ng Protocol for the Assessment of Arteriovenous Fistula Remodeling
arren J. Gasper,a Monica Sigovan,b Vitalliy Rayz,b Joseph Rapp,a David
aloner,b Christopher D. Owens,a aVascular Surgery and bRadiology, Uni-
ersity of California San Francisco, San Francisco, Calif.
Objective: To investigate the relationship of hemodynamic forces to
tructural remodeling in the maturing arteriovenous fistula (AVF), we
eveloped a rapid MRI-based AVF imaging protocol from a series of newly
reated and mature AVFs. In addition, we report, for the first time, use of a
on-gadolinium-based contrast agent, ferumoxytol, for contrast-enhanced
RA (CE-MRA) of an AVF.Methods: This was a cross-sectional study of subjects with stage IV or
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Volume 54, Number 2 Abstracts 593protocol consisted of 2D and 3D time of flight (TOF) sequences performed
at 1.5T (Siemens Avanto, Germany). Through-plane blood flow velocities in
the artery and vein were measured 3cm above the anastomosis with a 2D
phase contrast (PC) sequence. CE-MRA was done with superparamagnetic
iron oxide particles (ferumoxytol, AMAG, Lexington MA). Computational
fluid dynamics (CFD) simulations were performed using a finite volume
solver to determine velocity field and wall shear stress distributions (Fluent,
Lebanon NH).
Results: Twelve subjects (median age 67 years, IQR 59-76) had 22
scans. Among patients with a brachial artery AVF, the average arterial
diameter increased while arterial velocity and volumetric flow both increased
by 20 times, P  0.01. Both vein diameter and volumetric flow increased
after AVF surgery (Table). CFD demonstrated decreasing blood velocities
and asymmetric wall shear stress mappings along the AVF from 5 to 90 days
postop. Importantly, areas of stagnation persisted during this critical time
frame. Compared to TOF, ferumoxytol-enhanced MRA significantly in-
creased spatial resolution, increased fistula coverage (12.8cm vs 6cm) and
decreased imaging time (20 sec vs 3 min).
Conclusions: Development of a rapid, high-resolution MRI protocol
with CFD models, allowed for a comprehensive characterization of blood
vessel structure and hemodynamic forces in newly created and mature AVFs.
This MRI protocol is now being used prospectively to investigate the
relationship between hemodynamic forces, blood vessel remodeling and
AVF maturation. Additionally, ferumoxytol in CE-MRA shows promise as a
safe, non-invasive method for evaluating AVFs, especially non-maturing
AVFs and potentially other vascular structures in patients with end-stage
renal disease.
Important Predictors of DWI Lesions and Neurological Sequelae Fol-
lowing Carotid Intervention
Mohamed A. Zayed, MD, Jeffrey Stephens, Simin Gholibeikian, MD,
Shahrzad Ossareh, MD, Allyson Rosen, PhD, Barton Lane, MD, and Wei
Zhou, MD, Department of Surgery, Veterans Affairs Hospital Palo Alto,
Palo Alto, Calif.
Objectives: Embolic detection on diffusion weighted imaging (DWI)
by magnetic resonance imaging (MRI) is a promising outcome measure for
carotid interventions. We previously reported that patients undergoing
carotid artery stenting (CAS) have a 50% greater chance of developing new
microemboli on DWI compared to carotid endarterectomy (CEA). We
sought to re-evaluate these outcomes in a larger patient set after technical
modifications to our CAS program. We also examined the risk factors for
DWI lesions and correlated neurologic symptoms with DWI-derived MLV.
Methods: From July 2004 to December 2010, a total of 228 patients
(143 CEA, 85 CAS) who underwent carotid interventions also received
preoperative and postoperative DWI evaluations at a single academic insti-
tution. A novel neuroimaging analysis technique was used to derive MLV on
DWI. Hospital records for all patients were reviewed for comorbidities,
lesion characteristics, postoperative outcomes, and incidence of periproce-
dural microemboli.
Results: Forty patients (47%) with CAS compared to 15 patients (10%)
with CEA had postoperative DWI lesions (P .01), and a higher incidence
of contralateral microembolization (P .01). Multivariant analysis demon-
strated that the strongest predictors of DWI lesions after CAS or CEA were
body mass index (BMI)  30 (P  .01; confidence interval [CI], 1.4-8),
preoperative stroke (P .01; CI, 2.9-15.3), chronic obstructive pulmonary
disease (COPD; P  .03; CI, 1.1-6.2), and coronary artery disease (CAD;
P  .05; CI, 1-6.2; Table). Subset analysis of MLV demonstrated a signifi-
cant correlation with the incidence of postoperative neurological symptoms




Diameter, mm (SD) 4.5 (0.48)
Average velocity, cm/s (SD) 5.5 (3.2)a
Volumetric flow, mL/min (SD) 56 (33)a
Cephalic or basilic vein
Diameter, mm (SD) 3.7
Average velocity, cm/s (SD) 2.25
Volumetric flow, mL/min (SD) 14.8
Percent of blood flow in the distal artery N/A
Percent of blood flow in the venous limb N/A
aP .01, ANOVA.(P  .04; R2 0.248). MLV was not different between CAS and CEA (P 
.13).
s
eConclusion: The incidence of microembolic events after CAS is higher
ompared to CEA, but the MLV is similar for the two groups. DWI-derived
LV highly correlates with postprocedural neurological sequelas. Further
nvestigational use of periprocedural DWI is needed to determine the utility
nd cost-effectiveness of identifying patients at risk of neurological sequelas
fter carotid intervention.
able. Multivariant analysis of perioperative factors
actor P value CI









reoperative stroke  .01 2.9-15.3
arotid lesion calcification
MI, Body mass index; CAD, coronary artery disease; CI, confidence
nterval; COPD, chronic obstructive pulmonary disease; PVD, peripheral
ascular disease.
pregulation of Mitochondrial Chaperone Proteins in Vein Grafts: A
otential Mechanism of Apoptosis-Resistance in the Arterialized Vein
hanh P. Nguyen,a Christopher Owens, MD,a Pen-G Yu, MD,b Sara J.
unge, MD,a and Michael S. Conte, MD,a aDepartment of Surgery, Uni-
ersity of California – San Francisco, San Francisco, Calif; and bBrigham and
omen’s Hospital, Boston, Mass.
Objectives: Resistance to apoptosis is a salient feature of neoplasia and
eointimal hyperplasia. In cancer, a mitochondrial chaperone network con-
isting of heat shock proteins (HSP)75 and HSP90 mediates apoptosis-
esistance. We hypothesize that these mitochondrial proteins regulate sur-
ival in venous smooth muscle cells (VSMC) after arterialization, and may be
ritical in the hyperplastic response.
Methods: Primary cultured VSMC from human saphenous veins were
timulated with platelet-derived growth factors (PDGF)-BB (100 ng/mL)
r tumor necrosis factor- (TNF-; 10 ng/mL) for 24 hours. Cells were
ractionated for immunoblotting and cytosolic and mitochondrial fractions
robed for HSP75 and HSP90. Excised segments of diseased human vein
rafts (n  12) and control saphenous veins (n  10) were obtained from
iscarded specimens. Rabbits (n  9) underwent carotid interposition vein
rafting and grafts were harvested on day 5 or 28. Specimens were stained
or HSP75, HSP90, or the inducible isoform HSP90	.
Results: Immunoblotting showed that HSP90 and HSP75 were ex-
ressed primarily in the cytosol and mitochondria of VSMC, respectively.
itochondrial HSP75 was significantly increased after either cytokine or
rowth factor stimulation in vitro. After arterialization, HSP75 expression
as notably increased in all vein grafts. In the rabbit, both early (5 days, n







5.4 (0.56) 5.1 (0.41) 4.9 (1.8)
62 (17)a 70 (7)a 112.5 (57)a
850 (58)a 878 (225)a 1120 (236)a
4.8 (0.05) 4.7 (1.3) 13.2 (7.2)
55 (17) 64 (14) 15.7 (9.7)
596 (201) 733 (530) 1054 (492)
30% 17% 6%
70% 83% 94%Imtaining throughout the intima and media as compared to absent or minimal
xpression in control jugular veins (n  9; analysis of variance [ANOVA];
